Cargando…

Long noncoding RNA LINC00152 promotes cell proliferation through competitively binding endogenous miR‐125b with MCL‐1 by regulating mitochondrial apoptosis pathways in ovarian cancer

Recently, an increasing number of studies have focused on the key function of long noncoding RNAs (lncRNAs) in biological activity. Abnormal lncRNA expression was found to relate to the development and pathogenesis of multiple cancers. LncRNA LINC00152 served as an oncogene in multiple cancers; howe...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Puxiang, Fang, Xiaolin, Xia, Bing, Zhao, Yan, Li, Qiaoyan, Wu, Xiaoying
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6144155/
https://www.ncbi.nlm.nih.gov/pubmed/30030896
http://dx.doi.org/10.1002/cam4.1547
_version_ 1783356081227956224
author Chen, Puxiang
Fang, Xiaolin
Xia, Bing
Zhao, Yan
Li, Qiaoyan
Wu, Xiaoying
author_facet Chen, Puxiang
Fang, Xiaolin
Xia, Bing
Zhao, Yan
Li, Qiaoyan
Wu, Xiaoying
author_sort Chen, Puxiang
collection PubMed
description Recently, an increasing number of studies have focused on the key function of long noncoding RNAs (lncRNAs) in biological activity. Abnormal lncRNA expression was found to relate to the development and pathogenesis of multiple cancers. LncRNA LINC00152 served as an oncogene in multiple cancers; however, its role in ovarian cancer remains unknown. In our research study, LINC00152 was upregulated in ovarian cancer tissues and cell lines. An increasing LINC00152 level was positively correlated with the histological grade, clinical stage, and poor prognosis of ovarian cancer patients. In addition, knockdown of LINC00152 reduced cell growth, induced cell apoptosis, and suppressed tumor growth. Moreover, we revealed that LINC00152 and Myeloid cell leukemia‐1 (MCL‐1) were targeted by miR‐125b and had the same miR‐125b combining site. The miR‐125b level was negatively correlated with the expression of LINC00152, while MCL‐1 was positively related to the LINC00152 level. MiR‐125b could affect LINC00152 levels as evaluated by qRT‐PCR. Finally, we affirmed that LINC00152 mediated cell proliferation by affecting MCL‐1 expression and MCL‐1‐mediated mitochondrial apoptosis pathways and by working as a competitive endogenous RNA (ceRNA) of miR‐125b. In summary, based on ceRNA theory, the combined research on miR‐125b and MCL‐1, and taking LINC00152 as a new study point, we provide new insight into the molecular mechanism of reversing cell proliferation in ovarian cancer.
format Online
Article
Text
id pubmed-6144155
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-61441552018-09-24 Long noncoding RNA LINC00152 promotes cell proliferation through competitively binding endogenous miR‐125b with MCL‐1 by regulating mitochondrial apoptosis pathways in ovarian cancer Chen, Puxiang Fang, Xiaolin Xia, Bing Zhao, Yan Li, Qiaoyan Wu, Xiaoying Cancer Med Cancer Biology Recently, an increasing number of studies have focused on the key function of long noncoding RNAs (lncRNAs) in biological activity. Abnormal lncRNA expression was found to relate to the development and pathogenesis of multiple cancers. LncRNA LINC00152 served as an oncogene in multiple cancers; however, its role in ovarian cancer remains unknown. In our research study, LINC00152 was upregulated in ovarian cancer tissues and cell lines. An increasing LINC00152 level was positively correlated with the histological grade, clinical stage, and poor prognosis of ovarian cancer patients. In addition, knockdown of LINC00152 reduced cell growth, induced cell apoptosis, and suppressed tumor growth. Moreover, we revealed that LINC00152 and Myeloid cell leukemia‐1 (MCL‐1) were targeted by miR‐125b and had the same miR‐125b combining site. The miR‐125b level was negatively correlated with the expression of LINC00152, while MCL‐1 was positively related to the LINC00152 level. MiR‐125b could affect LINC00152 levels as evaluated by qRT‐PCR. Finally, we affirmed that LINC00152 mediated cell proliferation by affecting MCL‐1 expression and MCL‐1‐mediated mitochondrial apoptosis pathways and by working as a competitive endogenous RNA (ceRNA) of miR‐125b. In summary, based on ceRNA theory, the combined research on miR‐125b and MCL‐1, and taking LINC00152 as a new study point, we provide new insight into the molecular mechanism of reversing cell proliferation in ovarian cancer. John Wiley and Sons Inc. 2018-07-20 /pmc/articles/PMC6144155/ /pubmed/30030896 http://dx.doi.org/10.1002/cam4.1547 Text en © 2018 The Authors. Cancer Medicine published by John Wiley & Sons Ltd. This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
spellingShingle Cancer Biology
Chen, Puxiang
Fang, Xiaolin
Xia, Bing
Zhao, Yan
Li, Qiaoyan
Wu, Xiaoying
Long noncoding RNA LINC00152 promotes cell proliferation through competitively binding endogenous miR‐125b with MCL‐1 by regulating mitochondrial apoptosis pathways in ovarian cancer
title Long noncoding RNA LINC00152 promotes cell proliferation through competitively binding endogenous miR‐125b with MCL‐1 by regulating mitochondrial apoptosis pathways in ovarian cancer
title_full Long noncoding RNA LINC00152 promotes cell proliferation through competitively binding endogenous miR‐125b with MCL‐1 by regulating mitochondrial apoptosis pathways in ovarian cancer
title_fullStr Long noncoding RNA LINC00152 promotes cell proliferation through competitively binding endogenous miR‐125b with MCL‐1 by regulating mitochondrial apoptosis pathways in ovarian cancer
title_full_unstemmed Long noncoding RNA LINC00152 promotes cell proliferation through competitively binding endogenous miR‐125b with MCL‐1 by regulating mitochondrial apoptosis pathways in ovarian cancer
title_short Long noncoding RNA LINC00152 promotes cell proliferation through competitively binding endogenous miR‐125b with MCL‐1 by regulating mitochondrial apoptosis pathways in ovarian cancer
title_sort long noncoding rna linc00152 promotes cell proliferation through competitively binding endogenous mir‐125b with mcl‐1 by regulating mitochondrial apoptosis pathways in ovarian cancer
topic Cancer Biology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6144155/
https://www.ncbi.nlm.nih.gov/pubmed/30030896
http://dx.doi.org/10.1002/cam4.1547
work_keys_str_mv AT chenpuxiang longnoncodingrnalinc00152promotescellproliferationthroughcompetitivelybindingendogenousmir125bwithmcl1byregulatingmitochondrialapoptosispathwaysinovariancancer
AT fangxiaolin longnoncodingrnalinc00152promotescellproliferationthroughcompetitivelybindingendogenousmir125bwithmcl1byregulatingmitochondrialapoptosispathwaysinovariancancer
AT xiabing longnoncodingrnalinc00152promotescellproliferationthroughcompetitivelybindingendogenousmir125bwithmcl1byregulatingmitochondrialapoptosispathwaysinovariancancer
AT zhaoyan longnoncodingrnalinc00152promotescellproliferationthroughcompetitivelybindingendogenousmir125bwithmcl1byregulatingmitochondrialapoptosispathwaysinovariancancer
AT liqiaoyan longnoncodingrnalinc00152promotescellproliferationthroughcompetitivelybindingendogenousmir125bwithmcl1byregulatingmitochondrialapoptosispathwaysinovariancancer
AT wuxiaoying longnoncodingrnalinc00152promotescellproliferationthroughcompetitivelybindingendogenousmir125bwithmcl1byregulatingmitochondrialapoptosispathwaysinovariancancer